Wanbury informs about quarterly statement on investor complaints

15 Jul 2016 Evaluate

Wanbury has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Wanbury Share Price

280.05 -3.45 (-1.22%)
23-Dec-2024 09:38 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1799.60
Dr. Reddys Lab 1349.00
Cipla 1463.55
Lupin 2134.25
Zydus Lifesciences 966.40
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.